HomeGreater Than Icon
Indoco Remedies LtdGreater Than Icon
Indoco Remedies Ltd Financials
Company Logo

Indoco Remedies Ltd Financial Statement

Indoco Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
Revenue400.73
Operating Expense343.66
Net Profit12.79
Net Profit Margin3.19
Earning Per Share1.39
EBIDTA55.72
Effective Tax Rate5.68

Indoco Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,790.81
Operating Expenses Annual1,532.82
Operating Profit Annual278.02
Interest Annual36.81
Depreciation57.94
Net Profit Annual116.64
Tax Annual36.58

Indoco Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning9.99
Cash Flow from Operations176.78
Cash Flow from Investing-301.70
Cash Flow from Financing122.40
Cash Flow at the End7.47

Indoco Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)15.52
PBIT Margin (%)10.61
PBT Margin (%)10.32
Net PROFIT Margin (%)6.51
Return On Networth / Equity (%)10.83
Return On Networth /Employed (%)12.31
Return On Assets (%)7.56
Total Debt / Equity (X)0.39
Asset Turnover Ratio (%)1.16

Indoco Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual754.28
Total Current Assets Annual900.21
Non Current Assets Annual1,060.39
Total Shareholders Funds Annual1,126.62
Total Assets Annual1,960.61

Indoco Remedies Ltd Earning Calls

EPS (INR)

Expected

0.00

Reported

-1.09

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Mar 2024

EPS beaten by -28.57%

Dec 2023

EPS beaten by -2.85%

Get Your FAQs Right

As of Nov 5, 2024, Indoco Remedies Ltd has a market capitalization of 3,027.14 Cr. Value Research classifies it as a Mid-Cap company.
Yes, Indoco Remedies Ltd is debt-free with a debt-to-equity ratio of 0.46.
In FY 2023 , Indoco Remedies Ltd recorded a total revenue of approximately 1,761.95 Cr marking a significant milestone in the company's financial performance.
Indoco Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.1% and 0.1% annually, respectively..
Indoco Remedies Ltd's current PE ratio is 25.95.
Indoco Remedies Ltd's ROCE averaged 16.3% from the FY ending March 2022 to 2024, with a median of 15.8%. It peaked at 21.4% in March 2022, reflecting strong capital efficiency over the period..
Indoco Remedies Ltd's latest EBIT is Rs. 190.04 Cr, surpassing the average EBIT of Rs. 219.01 Cr over the 5 years..